Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy

Gynecologic Oncology

Volumn 140, Issue 1, 2016, Pages 101-106

  Johansen, Nora ^a,b   Liavaag, Astrid H ^a,b   Tanbo, Tom G ^c,d   Dahl, Alv A ^d   Pripp, Are H ^e   Michelsen, Trond M ^b,d,e  

^a Sorlandet Hospital   (Norway)

^b SØRLANDET HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

BRCA mutation; Controls; Hormone replacement therapy; Risk reducing salpingo oophorectomy; Sexual activity and functioning

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEHAVIOR ASSESSMENT; BODY IMAGE; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICAL INFORMATION; NEOPLASM; PLEASURE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCING SALPINGOOOPHORECTOMY; SALPINGOOOPHORECTOMY; SEXUAL ACTIVITY QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY; SURGICAL RISK; ADVERSE EFFECTS; BREAST NEOPLASMS; CASE CONTROL STUDY; DRUG EFFECTS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PHYSIOLOGY; PROCEDURES; SALPINGECTOMY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BODY IMAGE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PLEASURE; RETROSPECTIVE STUDIES; SALPINGECTOMY; SEXUAL BEHAVIOR; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84951826231     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.11.016     Document Type: Article

References (29)

1. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J. Clin. Oncol. 25 2007 1329 1333
2. A. Antoniou, P.D. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, and et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am. J. Hum. Genet. 72 2003 1117 1130
3. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, B. Rosen, and et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation J. Am. Med. Assoc. 296 2006 185 192
4. D.G. Evans, K.N. Gaarenstroom, D. Stirling, A. Shenton, L. Maehle, A. Dorum, and et al. Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers J. Med. Genet. 46 2009 593 597
5. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J. Natl. Cancer Inst. 101 2009 80 87
6. S.M. Domchek, T.M. Friebel, C.F. Singer, D.G. Evans, H.T. Lynch, C. Isaacs, and et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality J. Am. Med. Assoc. 304 2010 967 975
7. C. Marchetti, F. De Felice, I. Palaia, G. Perniola, A. Musella, D. Musio, and et al. Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers BMC Womens Health 14 2014 150
8. N.D. Kauff, and R.R. Barakat Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2 J. Clin. Oncol. 25 2007 2921 2927
9. M.B. Daly, R. Pilarski, J.E. Axilbund, M. Berry, S.S. Buys, M. Farmer, and et al. Genetic/familial high-risk assessment Breast and Ovarian. NCCN Clinical Practice Guidelines in Oncology 2015
10. The 2012 hormone therapy position statement of: the North American menopause society Menopause 19 2012 257 271
11. M.J. Gast, M.A. Freedman, A.J. Vieweg, N.R. De Melo, M.J. Girao, and M.J. Zinaman A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women Menopause 16 2009 247 256
12. M.E. Wierman, R.E. Nappi, N. Avis, S.R. Davis, F. Labrie, W. Rosner, and et al. Endocrine aspects of women's sexual function J. Sex Med. 7 2010 561 585
13. W. Somboonporn, S. Davis, M.W. Seif, and R. Bell. Testosterone for peri- and postmenopausal women. The Cochrane Database of Systematic Reviews. 2005 Cd004509
14. A. Finch, K.A. Metcalfe, J.K. Chiang, L. Elit, J. McLaughlin, C. Springate, and et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol. Oncol. 121 2011 163 168
15. J.B. Madalinska, M. van Beurden, E.M. Bleiker, H.B. Valdimarsdottir, J. Hollenstein, L.F. Massuger, and et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J. Clin. Oncol. 24 2006 3576 3582
16. K. Thirlaway, L. Fallowfield, and J. Cuzick The sexual activity questionnaire: a measure of women's sexual functioning Qual. Life Res. 5 1996 81 90
17. N.K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, N.J. Duez, and et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J. Natl. Cancer Inst. 85 1993 365 376
18. P. Hopwood, I. Fletcher, A. Lee, and G.S. Al A body image scale for use with cancer patients Eur. J. Cancer 37 2001 189 197
19. J.B. Madalinska, J. Hollenstein, E. Bleiker, M. van Beurden, H.B. Valdimarsdottir, L.F. Massuger, and et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J. Clin. Oncol. 23 2005 6890 6898
20. A.H. Liavaag, A. Dorum, T. Bjoro, H. Oksefjell, S.D. Fossa, C. Trope, and et al. A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach Gynecol. Oncol. 108 2008 348 354
21. B. Traeen, and H. Stigum Sexual problems in 18-67-year-old Norwegians Scand.J. Public Health 38 2010 445 456
22. L. Gallicchio, C. Schilling, D. Tomic, S.R. Miller, H. Zacur, and J.A. Flaws Correlates of sexual functioning among mid-life women Climact. J.e Int. Menopause Soc. 10 2007 132 142
23. S.R. Davis, and G.D. Braunstein Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women J. Sex Med. 9 2012 1134 1148
24. J.A. Simon, S.A. Kingsberg, B. Shumel, V. Hanes, M. Garcia Jr., and M. Sand Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial Menopause 21 2014 633 640
25. K.L. Edlefsen, R.D. Jackson, R.L. Prentice, I. Janssen, A. Rajkovic, M.J. O'Sullivan, and et al. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women Menopause 17 2010 622 629
26. A. Field Discovering Statistics Using IBM SPSS Statistics 2013 SAGE Los Angeles, London, New Delhi, Singapore, Washington DC
27. J. Cohen Statistical Power Analysis for the Behavioral Sciences 1988 Lawrence Erlbaum Associates Hillsdale, NJ
28. T. Faresjo, and A. Faresjo To match or not to match in epidemiological studies-same outcome but less power Int. J. Environ. Res. Public Health 7 2010 325 332
29. T.M. Michelsen, A. Dorum, and A.A. Dahl A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer Gynecol. Oncol. 113 2009 128 133